Novel and Potent SHIP1 Inhibitors for Improving Hematologic Recovery Following Myelosuppressive Therapies

Project: Research project

StatusActive
Effective start/end date6/10/195/31/20

Funding

  • National Institutes of Health/DHHS
  • Alterna Therapeutics